Beryl Drugs Ltd. Announces 33rd Annual Report 2025-2026

Beryl Drugs Ltd. has filed its Annual Report for the Financial Year 2025-2026, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report includes the Balance Sheet as of March 31, 2026, and the Statement of Profit and Loss and Cash Flow for the year ended on the same date. It also contains the Board's Report, Corporate Governance Report, and Auditor's Report. The company will hold its 33rd Annual General Meeting on Tuesday, September 29, 2026, at 11:00 AM at Kanchan Palace, Community Hall, Nipania Ring Road, Indore. Key corporate information, including registered office details, secretarial auditors, bankers, listed stock exchanges, board of directors, key managerial personnel, statutory auditors, and registrar and share transfer agents, are provided. The report also details the committees of the board: Audit Committee, Nomination & Remuneration Committee, and Stakeholders’ Relationship Committee.